ArticleEuropean journal of case reports in internal medicine2026
Sequential Systemic Thrombolysis for Clot-In-Transit after Thrombolytic Failure in Massive Pulmonary Embolism.
Article in European journal of case reports in internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: A clot-in-transit (CIT) is a mobile thrombus within the right heart associated with acute pulmonary embolism (PE) and high mortality. Although systemic thrombolysis remains the standard treatment for massive or high-risk PE, management of thrombolytic failure and associated CIT remains challenging, particularly when surgical embolectomy and catheter-directed thrombectomy are unavailable. Sequential systemic thrombolysis represents a practical therapeutic option in these high-risk scenarios. Case description: A 54-year-old woman with hypertension presented with progressive dyspnoea and pleuritic chest pain. Computed tomography pulmonary angiography confirmed massive bilateral PE, and she was treated with intravenous tenecteplase. Despite initial hemodynamic improvement, hypoxemia persisted, and echocardiography revealed a large CIT within the right atrium. In the absence of surgical or catheter-directed options, she received repeat systemic thrombolysis with alteplase, achieving complete thrombus resolution and rapid clinical recovery without bleeding complications. Further evaluation revealed large uterine fibroids compressing the iliac veins as the likely source of extensive deep vein thrombosis. Discussion: This case demonstrates the potential role of sequential systemic thrombolysis in managing thrombolytic failure and CIT when advanced interventions are unavailable. Switching to alteplase after unsuccessful thrombolysis with tenecteplase may enhance thrombus dissolution due to pharmacological differences in fibrin affinity and duration of fibrinolytic activity. Early reassessment following thrombolysis is critical to detect persistent thrombus and guide timely intervention. Conclusion: Sequential systemic thrombolysis can serve as a safe, effective, and practical rescue strategy for clot-in-transit complicating massive PE, particularly in low-resource settings where surgical or catheter-based interventions are not available. LEARNING POINTS: Sequential systemic thrombolysis can be a safe and effective rescue option following thrombolytic failure in massive pulmonary embolism.Early echocardiographic reassessment is essential to detect treatment failure and guide further therapy.Large uterine fibroids can cause iliac vein compression and predispose to extensive deep vein thrombosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.